Runben Biotechnology Co Ltd
SSE:603193
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Runben Biotechnology Co Ltd
Accounts Receivables
Runben Biotechnology Co Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Runben Biotechnology Co Ltd
SSE:603193
|
Accounts Receivables
¥13.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Shenzhen Breo Technology Co Ltd
SSE:688793
|
Accounts Receivables
¥53.7m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
D
|
Dencare Chongqing Oral Care Co Ltd
SZSE:001328
|
Accounts Receivables
¥23.4m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Minsheng Healthcare Co Ltd
SZSE:301507
|
Accounts Receivables
¥47m
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
M
|
Mao Geping Cosmetics Co Ltd
HKEX:1318
|
Accounts Receivables
¥240.6m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Runben Biotechnology Co Ltd
Glance View
Runben Biotechnology Co., Ltd. engages in the research and development, manufacture, and sale of mosquito repellent, baby care products, and personal care products. The company is headquartered in Guangzhou, Guangdong and currently employs 917 full-time employees. The company went IPO on 2023-10-17. The firm's main products can be divided into three sectors: mosquito repellent products, baby care products and essential oil products. The firm's principal products include electric mosquito repellent liquid, DEET mosquito repellent liquid, lipstick, face cream, facial cleanser, skin care cream and others. The firm mainly provides products to consumers through Internet sales models such as online direct sales, online platform distribution, and online platform agency sales. The firm mainly conducts its businesses in the domestic market.
See Also
What is Runben Biotechnology Co Ltd's Accounts Receivables?
Accounts Receivables
13.6m
CNY
Based on the financial report for Dec 31, 2024, Runben Biotechnology Co Ltd's Accounts Receivables amounts to 13.6m CNY.
What is Runben Biotechnology Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 1Y
182%
Over the last year, the Accounts Receivables growth was 182%.
